Product
Meglumine Antimoniate
2 clinical trials
2 indications
Indication
Cutaneous LeishmaniasisIndication
Native American myxoid fibrosarcomaClinical trial
Efficacy and Safety of Thermotherapy in Combination With Miltefosine Compared Iltefosine Monotherapy for the Treatment of New World Cutaneous Leishmaniasis: A Phase III, Open Label, Multicenter Randomized TrialStatus: Active (not recruiting), Estimated PCD: 2023-11-17
Clinical trial
Tofacitinib Associated With Meglumine Antimoniate in the Control of American Tegumentary Leishmaniasis. A Randomized and Controlled Clinical Trial.Status: Not yet recruiting, Estimated PCD: 2024-10-01